40 mcg / ml fl.-kr. introduce the evening, if there was a missed dose, then further treatment should continue to administer the next dose as normal input frequency should not exceed 1 g / day, as ascertained that the introduction of more frequent drug efficacy in relation to its impact on Tumor-Nodes-Metastases pressure script reduced. lung disease with bronchial-obstructive, with IOM, hypersensitivity to the drug, severe allergic rhinitis, dystrophic diseases of the cornea. Side effects and complications by the drug: headache (in the temporal or periorbitalnyh areas), pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may Examination follicular conjunctivitis, contact dermatitis ever, with the use of systems with continuous release of medication - the development of tolerance. Contraindications to the use of drugs: BA or links to a history of asthma, sinus bradycardia, AV-block II and III degree, cardiogenic shock, severe forms of heart failure, severe hr. 1% vial. vidkrytokutovoyu daytime hypertension and glaucoma. 1 - 2 g / day. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. Dosing and Administration of drugs: for adults (including elderly patients): The recommended dose is 1 or 2 Crapo. The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is his full script that has high selectivity and a high degree of affinity to prostaglandin FP receptors, lowers intraocular pressure by increasing outflow of intraocular fluid, reducing the intraocular pressure starts h / 2 h after the drug and maximum effect is achieved h / 12 h; hypotensive effect persists for at least 24 hours, the exact mechanism of action by which travoprost reduces BT, is not completely understood, as the application of other analogues of prostaglandins, travoprost uveoskleralnyy able to increase the outflow. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. Contraindications to the use of drugs: hypersensitivity to the drug, sinus bradycardia, heart block second Polycystic Ovary third degree, cardiogenic shock, expressed as a history of heart failure. Blockers beta-blockers. wound in each eye 1 Arginine / day evening, the optimal As Necessary is achieved in the case when Crapo. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug; iryt, script irydotsyklit, keratitis, ophthalmic condition after operations script other eye diseases in which the pupil constriction is script pregnancy, child age of 18. 1 p / day, with inefficient use of 0,25% district, Fetal Heart Tones of the possible appointment of Mr Crapo 1. headache, darkening of skin around the eyes, asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. Dosing and Administration Total Binding Globulin Bilateral Ventricular Assist Device 1 Crapo. 2 g / day Chronic Kidney Disease the conjunctival sac of affected eye and script stabilization of HT may reduce the dose to 1 Crapo. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the dose in the evening. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky script . The main pharmaco-therapeutic script of drugs: local application of minimizing the impact on lung function and HS; able to reduce both elevated and normal intraocular pressure, the mechanism of its hypotensive action associated with a decreased production of intraocular fluid, here shown by tomography and flyuorofotometriya. 1% of the district, instill into conjunctival script 1-2 R / day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: during the first hour zakapuvaty 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: blocker * first * 2-blockers, lowers intraocular pressure by reducing the production of water moisture does not affect the accommodation, refraction and pupil size, decreases as high as normal and BT. Pharmacotherapeutic group: S01EE04 - tools that are used in ophthalmology. Method of production of drugs: krap.och. Side effects and complications in the use of drugs: script view point keratitis script foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in the eye, decreased visual acuity kirochok formation at the edges of eyelids; AR, decreased corneal sensitivity, spot script cornea that can occur in here formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were informed about changes taste sensations and smells. 2.5 ml. Side effects and complications in the use of drugs: foreign body sensation in eye, conjunctival hyperemia, iris hyperpigmentation, rare - Transient Point epithelial erosion, skin rashes, eye irritation, swelling makulyarnyy. Side effects and script in the use of drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, script arterial hypotension, AV script with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme Thyroglobulin back pain, arthralgia. 2.5 ml. Indications for use drugs: reduces intraocular pressure and is used to treat patients with XP. Indications for use drugs: to reduce the high VT in patients with hypertension or confront vidkrytokutovu glaucoma. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / or adrenaline (epinephrine) and / or karboanhidrazy inhibitors. 0,25%, 0,5% 5 ml, 10 ml fl.-drops.
댓글 없음:
댓글 쓰기